Show simple item record

Evaluation of a new optical immunoassay for diagnosis of neonatal chlamydial conjunctivitis.

dc.contributor.authorRoblin, P M
dc.contributor.authorGelling, M
dc.contributor.authorKutlin, A
dc.contributor.authorTsumura, N
dc.contributor.authorHammerschlag, M R
dc.date.accessioned2023-06-30T16:29:23Z
dc.date.available2023-06-30T16:29:23Z
dc.date.issued1997-02
dc.identifier.citationRoblin PM, Gelling M, Kutlin A, Tsumura N, Hammerschlag MR. Evaluation of a new optical immunoassay for diagnosis of neonatal chlamydial conjunctivitis. J Clin Microbiol. 1997 Feb;35(2):515-6. doi: 10.1128/jcm.35.2.515-516.1997. PMID: 9003631; PMCID: PMC229615.en_US
dc.identifier.issn0095-1137
dc.identifier.pmid9003631
dc.identifier.urihttp://hdl.handle.net/20.500.12648/10341
dc.description.abstractThe BioStar OIA Chlamydia test (BioStar, Inc., Boulder, Colo.) is a novel immunoassay system that uses changes in reflection of light to directly detect chlamydial antigen in clinical specimens. We compared the optical immunoassay (OIA) with culture for detecting Chlamydia trachomatis in ocular specimens from infants with suspected chlamydial conjunctivitis. We initially performed a retrospective evaluation, testing 152 ocular specimens previously collected for culture with the OIA. The sensitivity and specificity were 94.2 and 97%, respectively. A subsequent prospective study evaluating 37 ocular specimens from infants with suspected C. trachomatis conjunctivitis revealed a sensitivity and specificity of 100 and 92.6%, respectively.
dc.language.isoenen_US
dc.relation.urlhttps://journals.asm.org/doi/epdf/10.1128/jcm.35.2.515-516.1997en_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleEvaluation of a new optical immunoassay for diagnosis of neonatal chlamydial conjunctivitis.en_US
dc.typeArticle/Reviewen_US
dc.source.journaltitleJournal of clinical microbiologyen_US
dc.source.volume35
dc.source.issue2
dc.source.beginpage515
dc.source.endpage6
dc.source.countryUnited States
dc.description.versionVoRen_US
refterms.dateFOA2023-06-30T16:29:26Z
html.description.abstractThe BioStar OIA Chlamydia test (BioStar, Inc., Boulder, Colo.) is a novel immunoassay system that uses changes in reflection of light to directly detect chlamydial antigen in clinical specimens. We compared the optical immunoassay (OIA) with culture for detecting Chlamydia trachomatis in ocular specimens from infants with suspected chlamydial conjunctivitis. We initially performed a retrospective evaluation, testing 152 ocular specimens previously collected for culture with the OIA. The sensitivity and specificity were 94.2 and 97%, respectively. A subsequent prospective study evaluating 37 ocular specimens from infants with suspected C. trachomatis conjunctivitis revealed a sensitivity and specificity of 100 and 92.6%, respectively.
dc.description.institutionSUNY Downstateen_US
dc.description.departmentPediatricsen_US
dc.description.degreelevelN/Aen_US
dc.identifier.journalJournal of clinical microbiology
dc.identifier.issue2en_US


Files in this item

Thumbnail
Name:
jcm.35.2.515-516.1997.pdf
Size:
140.7Kb
Format:
PDF
Download

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International